Health Care Innovation
Blog
Newsom’s ‘Bold’ Plan on Prescription Drugs Won’t Really Help Patients, Lower Drug Costs
In a state where the private sector continues to be marginalized in favor of more government, Gov. Gavin Newsom has plans for California to set up a generic drug label of its own. It would be the first state in the country to go into the pharmaceutical business, and will ...
Kerry Jackson
January 27, 2020
Commentary
Price Controls Impose High Costs On Patients
Twenty-five years ago, the leading cause of death for adults between the ages of 25 and 44 was complications from HIV. At the time, 50,000 Americans were dying from AIDS-related causes a year, with the African American community particularly hard hit – 49 percent of the people dying from AIDS-related deaths ...
Wayne Winegarden
January 23, 2020
Drug Pricing
Wayne Winegarden Drug Pricing Study Featured in Healthcare Finance News
Drug supply chain, pricing system reforms will slash healthcare costs, says PRI By Jeff Lagasse As the Trump administration pushes for price caps and government controls to address prescription drug prices, a new issue brief released by the Center for Medical Economics and Innovation at the Pacific Research Institute contends ...
Pacific Research Institute
January 23, 2020
Drug Pricing
Wayne Winegarden – Why the Pelosi and Newsom Approaches to Prescription Drugs Won’t Really Help Patients
Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, breaks down recently-proposed plans in Washington and Sacramento that emphasize price caps and more government control to address prescription drug prices. He discusses the conclusions of his new study on America’s drug pricing challenge, which makes the case ...
Pacific Research Institute
January 13, 2020
Blog
Lies, Damn Lies, and Drug Price Increases
As each new year begins, the increases in the list prices of drugs are announced. And, following these announcements, the political class complains that something must be done. This year, following the price announcements, Speaker Nancy Pelosi tweeted “Enough is enough” while Senator Grassley emphasized that a “call to action” ...
Wayne Winegarden
January 8, 2020
Drug Pricing
NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs
As Washington pushes for price caps and government controls to address prescription drug prices, a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute argues that reforming the complex drug supply chain and ending the current drug pricing system that overcharges ...
Wayne Winegarden
January 8, 2020
Commentary
America’s Critical Medical Device Industry Gets A Needed Tax Cut
Medical devices may not be as glamorous as blockbuster drugs, but they include some of the genuine miracles of modern medicine: pacemakers, artificial joints, replacement heart valves, scanners, and cancer radiation-therapy machines. The U.S. has been the global leader in medical devices, one of the few major industries that both ...
Henry Miller, M.S., M.D.
December 26, 2019
Commentary
Court ruling leaves problem-plagued ObamaCare’s future unknown – More pragmatic plan needed
ObamaCare’s much-hated requirement that every American carry health insurance or pay a penalty was ruled unconstitutional Wednesday in a 2-1 decision by the 5th U.S. Circuit Court of Appeals. That’s the right decision on a badly flawed law – but it won’t change anything for months or more likely years ...
Sally C. Pipes
December 20, 2019
Commentary
The Deep State Will Challenge the New FDA Head
Now that the Trump Administration’s new FDA commissioner, Dr. Stephen Hahn, has been confirmed, he’ll find he has one of the most difficult and important jobs in government. The FDA’s purview is wide, regulating pharmaceutical and other medical, food, and vaping products that account for more than 25 cents of ...
Pacific Research Institute
December 19, 2019
Commentary
To Help Patients, Reform The Drug Pricing System Don’t Impose Price Controls
Yesterday the House passed the ill-considered “Pelosi bill” that would impose draconian price controls on drugs. Ignoring the bill’s many adverse impacts, price control advocates like Speaker Pelosi appear to believe that these command and control schemes can solve the systemic health care affordability problem. But, as the latest government data illustrates, ...
Wayne Winegarden
December 13, 2019
Newsom’s ‘Bold’ Plan on Prescription Drugs Won’t Really Help Patients, Lower Drug Costs
In a state where the private sector continues to be marginalized in favor of more government, Gov. Gavin Newsom has plans for California to set up a generic drug label of its own. It would be the first state in the country to go into the pharmaceutical business, and will ...
Price Controls Impose High Costs On Patients
Twenty-five years ago, the leading cause of death for adults between the ages of 25 and 44 was complications from HIV. At the time, 50,000 Americans were dying from AIDS-related causes a year, with the African American community particularly hard hit – 49 percent of the people dying from AIDS-related deaths ...
Wayne Winegarden Drug Pricing Study Featured in Healthcare Finance News
Drug supply chain, pricing system reforms will slash healthcare costs, says PRI By Jeff Lagasse As the Trump administration pushes for price caps and government controls to address prescription drug prices, a new issue brief released by the Center for Medical Economics and Innovation at the Pacific Research Institute contends ...
Wayne Winegarden – Why the Pelosi and Newsom Approaches to Prescription Drugs Won’t Really Help Patients
Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, breaks down recently-proposed plans in Washington and Sacramento that emphasize price caps and more government control to address prescription drug prices. He discusses the conclusions of his new study on America’s drug pricing challenge, which makes the case ...
Lies, Damn Lies, and Drug Price Increases
As each new year begins, the increases in the list prices of drugs are announced. And, following these announcements, the political class complains that something must be done. This year, following the price announcements, Speaker Nancy Pelosi tweeted “Enough is enough” while Senator Grassley emphasized that a “call to action” ...
NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs
As Washington pushes for price caps and government controls to address prescription drug prices, a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute argues that reforming the complex drug supply chain and ending the current drug pricing system that overcharges ...
America’s Critical Medical Device Industry Gets A Needed Tax Cut
Medical devices may not be as glamorous as blockbuster drugs, but they include some of the genuine miracles of modern medicine: pacemakers, artificial joints, replacement heart valves, scanners, and cancer radiation-therapy machines. The U.S. has been the global leader in medical devices, one of the few major industries that both ...
Court ruling leaves problem-plagued ObamaCare’s future unknown – More pragmatic plan needed
ObamaCare’s much-hated requirement that every American carry health insurance or pay a penalty was ruled unconstitutional Wednesday in a 2-1 decision by the 5th U.S. Circuit Court of Appeals. That’s the right decision on a badly flawed law – but it won’t change anything for months or more likely years ...
The Deep State Will Challenge the New FDA Head
Now that the Trump Administration’s new FDA commissioner, Dr. Stephen Hahn, has been confirmed, he’ll find he has one of the most difficult and important jobs in government. The FDA’s purview is wide, regulating pharmaceutical and other medical, food, and vaping products that account for more than 25 cents of ...
To Help Patients, Reform The Drug Pricing System Don’t Impose Price Controls
Yesterday the House passed the ill-considered “Pelosi bill” that would impose draconian price controls on drugs. Ignoring the bill’s many adverse impacts, price control advocates like Speaker Pelosi appear to believe that these command and control schemes can solve the systemic health care affordability problem. But, as the latest government data illustrates, ...